HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma.

Abstract
Epithelial ovarian cancer (EOC) consists of four major subtypes: clear cell carcinoma (CCC), endometrioid adenocarcinoma (EA), mucinous adenocarcinoma (MA) and serous adenocarcinoma (SA). Relative to the other subtypes, the prognosis of CCC is poor due to a high recurrence rate and chemotherapy resistance, but CCC-specific biomarkers have yet to be identified. With the aim of identifying diagnostic and treatment biomarkers for CCC, we analyzed 96 cases of EOC (32 CCC, 13 EA, 19 MA, 32 SA) using liquid chromatography/mass spectrometry (LC/MS) followed by immunohistochemistry (IHC) and quantitative reverse transcription PCR (RT-qPCR). Semi-quantification of protein differences between subtypes showed upregulation of 150 proteins and downregulation of 30 proteins in CCC relative to the other subtypes. Based on hierarchical clustering that revealed a marked distinction in the expression levels of cystatin B (CYTB) and Annexin A4 (ANXA4) in CCC relative to the other subtypes, we focused the study on CYTB and ANXA4 expression in EOCs by IHC, RT-qPCR and western blot analyses using tissue specimens and cultured cells. As a result, compared to the other subtypes, CCC showed significantly high expression levels of CYTB and ANXA4 in the analyses. To examine the possibility of CYTB and ANXA4 as serum diagnostic biomarkers of CCC, we checked the protein levels in conditioned media and cell lysates using culture cells. Compared with the other subtypes, CCC cell lines showed a significantly higher level of expression of CYTB in both conditioned media and cell lysates, while ANXA4 showed a higher level of expression in cell lysates only. Our results demonstrate that CYTB and ANXA4 overexpression may be related to carcinogenesis and histopathological differentiation of CCC. CYTB may be a secreted protein, and may serve as a potential serum diagnostic biomarker of CCC, while ANXA4 may be useful as an intracellular marker.
AuthorsAkane Takaya, Wei-Xia Peng, Kousuke Ishino, Mitsuhiro Kudo, Tetsushi Yamamoto, Ryuichi Wada, Toshiyuki Takeshita, Zenya Naito
JournalInternational journal of oncology (Int J Oncol) Vol. 46 Issue 4 Pg. 1573-81 (Apr 2015) ISSN: 1791-2423 [Electronic] Greece
PMID25633807 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Annexin A4
  • Biomarkers, Tumor
  • CSTB protein, human
  • Culture Media, Conditioned
  • Cystatin B
Topics
  • Adenocarcinoma, Clear Cell (blood, diagnosis, pathology)
  • Adult
  • Aged
  • Aged, 80 and over
  • Annexin A4 (genetics, metabolism)
  • Biomarkers, Tumor (blood, genetics, metabolism)
  • Cell Line, Tumor
  • Chromatography, Liquid (methods)
  • Culture Media, Conditioned (pharmacology)
  • Cystatin B (genetics, metabolism)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mass Spectrometry (methods)
  • Middle Aged
  • Ovarian Neoplasms (blood, diagnosis, pathology)
  • Real-Time Polymerase Chain Reaction (methods)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: